抑郁症中的淀粉样蛋白成像：阿尔茨海默病的预测指标？ - Suppr

Suppr

超能文献

Amyloid imaging in depression: a predictor of Alzheimer's disease?

作者信息

Camacho Valle, Lleó Alberto

机构信息

Nuclear Medicine Department, Hospital de Sant Pau, Autonomous University of Barcelona, Barcelona, Spain,

出版信息

Eur J Nucl Med Mol Imaging. 2014 Apr;41(4):711-3. doi: 10.1007/s00259-014-2741-7.

DOI:10.1007/s00259-014-2741-7

PMID:24604593

Abstract

摘要

相似文献

Amyloid imaging in depression: a predictor of Alzheimer's disease?

Eur J Nucl Med Mol Imaging. 2014 Apr;41(4):711-3. doi: 10.1007/s00259-014-2741-7.

Increased brain amyloid deposition in patients with a lifetime history of major depression: evidenced on 18F-florbetapir (AV-45/Amyvid) positron emission tomography.

Eur J Nucl Med Mol Imaging. 2014 Apr;41(4):714-22. doi: 10.1007/s00259-013-2627-0.

Beta amyloid imaging with positron emission tomography (PET) for evaluation of suspected Alzheimer's disease or other causes of cognitive decline.

Technol Eval Cent Assess Program Exec Summ. 2013 Feb;27(5):1-4.

Florbetapir (18F) for brain amyloid positron emission tomography: highlights on the European marketing approval.

Alzheimers Dement. 2014 Oct;10(5 Suppl):S395-9. doi: 10.1016/j.jalz.2013.09.007. Epub 2014 Jan 10.

Amyloid imaging: liberal or conservative? Let the data decide.

Arch Neurol. 2011 Nov;68(11):1377-8. doi: 10.1001/archneurol.2011.152. Epub 2011 Jul 11.

Radioactive agent approved as part of Alzheimer disease workup.

Am J Health Syst Pharm. 2012 May 15;69(10):818. doi: 10.2146/news120033.

Amyloid imaging in Alzheimer's disease: comparison of florbetapir and Pittsburgh compound-B positron emission tomography.

J Neurol Neurosurg Psychiatry. 2012 Sep;83(9):923-6. doi: 10.1136/jnnp-2012-302548. Epub 2012 Jul 11.

Brain amyloid imaging--FDA approval of florbetapir F18 injection.

N Engl J Med. 2012 Sep 6;367(10):885-7. doi: 10.1056/NEJMp1208061.

Beta-amyloid deposition and cognitive function in patients with major depressive disorder with different subtypes of mild cognitive impairment: (18)F-florbetapir (AV-45/Amyvid) PET study.

Eur J Nucl Med Mol Imaging. 2016 Jun;43(6):1067-76. doi: 10.1007/s00259-015-3291-3. Epub 2016 Jan 7.

Diversity of neurodegenerative pathophysiology in nondemented patients with major depressive disorder: Evidence of cerebral amyloidosis and hippocampal atrophy.

Brain Behav. 2018 Jul;8(7):e01016. doi: 10.1002/brb3.1016. Epub 2018 Jun 21.

本文引用的文献

Florbetapir (18F) for brain amyloid positron emission tomography: highlights on the European marketing approval.

Alzheimers Dement. 2014 Oct;10(5 Suppl):S395-9. doi: 10.1016/j.jalz.2013.09.007. Epub 2014 Jan 10.

Increased brain amyloid deposition in patients with a lifetime history of major depression: evidenced on 18F-florbetapir (AV-45/Amyvid) positron emission tomography.

Eur J Nucl Med Mol Imaging. 2014 Apr;41(4):714-22. doi: 10.1007/s00259-013-2627-0.

Late-life depression and risk of vascular dementia and Alzheimer's disease: systematic review and meta-analysis of community-based cohort studies.

Br J Psychiatry. 2013 May;202(5):329-35. doi: 10.1192/bjp.bp.112.118307.

Head-to-head comparison of 11C-PiB and 18F-AZD4694 (NAV4694) for β-amyloid imaging in aging and dementia.

J Nucl Med. 2013 Jun;54(6):880-6. doi: 10.2967/jnumed.112.114785. Epub 2013 Apr 10.

2013 Alzheimer's disease facts and figures.

Alzheimers Dement. 2013 Mar;9(2):208-45. doi: 10.1016/j.jalz.2013.02.003.

Appropriate use criteria for amyloid PET: a report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer's Association.

J Nucl Med. 2013 Mar;54(3):476-90. doi: 10.2967/jnumed.113.120618. Epub 2013 Jan 28.

Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers.

Lancet Neurol. 2013 Feb;12(2):207-16. doi: 10.1016/S1474-4422(12)70291-0.

Amyloid-β imaging with Pittsburgh compound B and florbetapir: comparing radiotracers and quantification methods.

J Nucl Med. 2013 Jan;54(1):70-7. doi: 10.2967/jnumed.112.109009. Epub 2012 Nov 19.

Amyloid imaging in Alzheimer's disease: comparison of florbetapir and Pittsburgh compound-B positron emission tomography.

J Neurol Neurosurg Psychiatry. 2012 Sep;83(9):923-6. doi: 10.1136/jnnp-2012-302548. Epub 2012 Jul 11.

Amyloid-β assessed by florbetapir F 18 PET and 18-month cognitive decline: a multicenter study.

Neurology. 2012 Oct 16;79(16):1636-44. doi: 10.1212/WNL.0b013e3182661f74. Epub 2012 Jul 11.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验